Clinical Trial Information for Technical Partners

Results from familial and sporadic disease must be separated.

Researchers lump in any number of human trialists from both familial, (usually around 10%), and sporadic diseases. No attempt is made to keep results from familial and sporadic diseases separate. Familial and sporadic results must be kept separate.


0 votes
Idea No. 896